Open AccessMesenchimal stem cells in treatment of cancer patients with COVID-19 pneumonia
Author(s) -
Ирина Балдуева,
Tatyaekhaeva,
Алексей Михайлович Беляев
Publication year - 2021
Publication title -
voprosy onkologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.108
H-Index - 11
eISSN - 2949-4915
pISSN - 0507-3758
DOI - 10.37469/0507-3758-2021-67-1-7-12
Subject(s) - pneumonia , mesenchymal stem cell , covid-19 , medicine , stem cell , pandemic , cancer , virus , respiratory system , immunology , cancer research , biology , pathology , disease , infectious disease (medical specialty) , genetics
The review discusses the pathogenetic mechanisms of the development of respiratory infection COVID-19 and the clinical use of cell technologies based on mesenchymal stem cells (MSCs). Due to the global pandemic of COVID-19/SARS-CoV-2 respiratory infection associated with the spread of the SARS-CoV-2 virus, and the difficulty in treating severe cases of infection, the immunomodulatory activity of MSCs due to inflammatory microenvironment factors can be used in the complex treatment of COVID-19 pneumonia, including in cancer patients.